Hypofractionated radiotherapy in the treatment of early breast cancer

scientific article

Hypofractionated radiotherapy in the treatment of early breast cancer is …
instance of (P31):
editorialQ871232
scholarly articleQ13442814

External links are
P356DOI10.4329/WJR.V2.I6.197
P932PMC publication ID2999325
P698PubMed publication ID21160631
P5875ResearchGate publication ID49685670

P2093author name stringGeorge Plataniotis
P2860cites workModeling killing and repopulation kinetics of subclinical cancer: direct calculations from clinical data.Q30891351
Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer?Q33603495
A shorter fractionation schedule for postlumpectomy breast cancer patientsQ33964210
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.Q34155828
Time-dose factors in radiotherapy: a review of the human data.Q34343444
Adjuvant radiotherapy for early breast cancer: patterns of practice in Ontario.Q34707063
Local recurrence of breast cancer following surgery and radiotherapy: incidence and outcomeQ35071917
Latest developments in local treatment: radiotherapy for early breast cancerQ36164319
Moving to a high-tech approach to the irradiation of early breast cancer: is it possible to balance efficacy, morbidity and resource use?Q36444763
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.Q36514573
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trialQ36571627
External hypofractionated whole-breast radiotherapy: now where does accelerated partial breast irradiation stand?Q37083182
Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic reviewQ37265690
Accelerated partial breast irradiation trials: diversity in rationale and designQ37380180
Biologically effective dose-response relationship for breast cancer treated by conservative surgery and postoperative radiotherapyQ37558840
The linear-quadratic formula and progress in fractionated radiotherapyQ38678064
Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancerQ44230659
Hypofractionation redux?Q44900657
Whole-breast radiotherapy with shorter fractionation schedules following breast-conserving surgery: short-term morbidity and preliminary outcomesQ46788398
Long-term results of hypofractionated radiation therapy for breast cancerQ48887913
Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial.Q50760966
Acute toxicity and 2-year adverse effects of 30 Gy in five fractions over 15 days to whole breast after local excision of early breast cancer.Q51118188
Hypofractionated radiotherapy for breast cancer patients treated by breast-conserving surgery: short-term morbidity and preliminary results.Q51836195
The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.Q52430649
Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy.Q53209409
Adjuvant Hypofractionated Radiation Therapy for Breast Cancer after Conserving SurgeryQ62652641
Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomised trialQ71474980
Late cosmetic results of short fractionation for breast conservationQ71877343
Seven-year follow-up on 334 patients treated by breast conserving surgery and short course radical postoperative radiotherapy: a report of the Yorkshire Breast Cancer GroupQ71910013
Dose-response relationship for radiation therapy of subclinical diseaseQ72463949
The Christie Hospital breast conservation trial: an update at 8 years from inceptionQ72766845
Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, FranceQ73132146
Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13Q73308515
Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative GroupQ73837095
Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancerQ78410812
Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trialQ80495823
P433issue6
P304page(s)197-202
P577publication date2010-06-01
P1433published inWorld journal of radiologyQ27723340
P1476titleHypofractionated radiotherapy in the treatment of early breast cancer
P478volume2

Reverse relations

cites work (P2860)
Q49590443A Comparative Study of Hypofractionated and Conventional Radiotherapy in Postmastectomy Breast Cancer Patients
Q35356286Assessment of contralateral mammary gland dose in the treatment of breast cancer using accelerated hypofractionated radiotherapy

Search more.